Zhihai Chen

7.2k total citations
87 papers, 1.5k citations indexed

About

Zhihai Chen is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Zhihai Chen has authored 87 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Epidemiology. Recurrent topics in Zhihai Chen's work include Viral Infections and Vectors (26 papers), COVID-19 Clinical Research Studies (20 papers) and SARS-CoV-2 and COVID-19 Research (16 papers). Zhihai Chen is often cited by papers focused on Viral Infections and Vectors (26 papers), COVID-19 Clinical Research Studies (20 papers) and SARS-CoV-2 and COVID-19 Research (16 papers). Zhihai Chen collaborates with scholars based in China, United States and Hong Kong. Zhihai Chen's co-authors include Congjie Gao, Sanchuan Yu, Meihong Liu, Zhenhua Lü, Jihua Nie, Xuesong Liu, Huaiqi Jing, Shiwen Wang, Jianguo Xu and Longze Luo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Zhihai Chen

78 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhihai Chen China 16 539 406 217 200 190 87 1.5k
Shiwen Wang China 19 1.2k 2.2× 207 0.5× 272 1.3× 208 1.0× 74 0.4× 70 2.1k
John Scott Meschke United States 27 923 1.7× 133 0.3× 411 1.9× 291 1.5× 71 0.4× 84 2.2k
Kwanrawee Sirikanchana Thailand 21 736 1.4× 146 0.4× 287 1.3× 82 0.4× 267 1.4× 56 1.4k
Robert J. Fischer United States 24 1.4k 2.7× 223 0.5× 96 0.4× 216 1.1× 68 0.4× 68 2.2k
Lifang Jiang China 22 504 0.9× 478 1.2× 27 0.1× 246 1.2× 236 1.2× 89 1.6k
Wendy Smith Australia 28 2.0k 3.7× 252 0.6× 120 0.6× 186 0.9× 260 1.4× 77 4.2k
Petros Kokkinos Greece 24 662 1.2× 48 0.1× 281 1.3× 84 0.4× 166 0.9× 53 1.8k
Chenglong Xiong China 19 864 1.6× 195 0.5× 24 0.1× 223 1.1× 164 0.9× 74 2.0k
Benu Dhawan India 27 681 1.3× 291 0.7× 50 0.2× 567 2.8× 70 0.4× 163 2.5k
Yolanda López‐Vidal Mexico 27 848 1.6× 132 0.3× 64 0.3× 528 2.6× 452 2.4× 122 2.5k

Countries citing papers authored by Zhihai Chen

Since Specialization
Citations

This map shows the geographic impact of Zhihai Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihai Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihai Chen more than expected).

Fields of papers citing papers by Zhihai Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihai Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihai Chen. The network helps show where Zhihai Chen may publish in the future.

Co-authorship network of co-authors of Zhihai Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihai Chen. A scholar is included among the top collaborators of Zhihai Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihai Chen. Zhihai Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhao, Chenxi, Yanli Xu, Xiaoyu Xue, et al.. (2025). Analysis of the clinical efficacy of CCBs in patients with severe fever with thrombocytopenia syndrome combined with hypertension. Virology Journal. 22(1). 184–184.
3.
Chang, Zhen, Junqing Sun, Gen Zhang, et al.. (2024). Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model. Proceedings of the National Academy of Sciences. 121(24). 12 indexed citations
4.
Zhao, Runchu, Lili Wu, Junqing Sun, et al.. (2024). Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections. Nature Communications. 15(1). 4660–4660. 20 indexed citations
5.
Liu, Lu, Yu Zhang, Di Xu, et al.. (2024). Overexpression of USP8 inhibits inflammation and ferroptosis in chronic obstructive pulmonary disease by regulating the OTUB1/SLC7A11 signaling pathway. Allergologia et Immunopathologia. 52(4). 60–67. 4 indexed citations
6.
Zhang, Yue, Li Lan, Yuanni Liu, et al.. (2024). Identification of CCL20 as a Prognostic Predictor for Severe Fever With Thrombocytopenia Syndrome Based on Plasma Proteomics. The Journal of Infectious Diseases. 230(3). 741–753. 2 indexed citations
7.
Liu, Zishuai, Rongling Zhang, Chenxi Zhao, et al.. (2024). Development and validation of the PLNA score to predict cytokine storm in acute-phase SFTS patients: A single-center cohort study. International Immunopharmacology. 136. 112288–112288. 4 indexed citations
8.
9.
Zhao, Runchu, Sheng Niu, Pu Han, et al.. (2023). Cross-species recognition of bat coronavirus RsYN04 and cross-reaction of SARS-CoV-2 antibodies against the virus. 动物学研究. 44(6). 1015–1025. 2 indexed citations
10.
Liu, Lu, Yu Zhang, Wei Wei, et al.. (2022). Ubiquitin-specific protease 8 inhibits lipopolysaccharide-triggered pyroptosis of human bronchial epithelial cells by regulating PI3K/AKT and NF-κB pathways. Allergologia et Immunopathologia. 50(2). 96–103. 13 indexed citations
11.
Hu, Yu, Kefang Liu, Pu Han, et al.. (2022). Host range and structural analysis of bat‐origin RshSTT182 /200 coronavirus binding to human ACE2 and its animal orthologs. The EMBO Journal. 42(4). e111737–e111737. 13 indexed citations
12.
Liu, Zishuai, Rongling Zhang, Yuanni Liu, et al.. (2022). Eosinophils and basophils in severe fever with thrombocytopenia syndrome patients: Risk factors for predicting the prognosis on admission. PLoS neglected tropical diseases. 16(12). e0010967–e0010967. 8 indexed citations
13.
Li, Yan, Zhihai Chen, Lili Wu, et al.. (2022). A neutralizing-protective supersite of human monoclonal antibodies for yellow fever virus. The Innovation. 3(6). 100323–100323. 5 indexed citations
14.
Liu, Jingyuan, Yuyong Jiang, Yao Liu, et al.. (2021). Yindan Jiedu Granules, a Traditional Chinese Medicinal Formulation, as a Potential Treatment for Coronavirus Disease 2019. Frontiers in Pharmacology. 11. 634266–634266. 6 indexed citations
15.
Chen, Zhihai, Wen Xie, Yajie Wang, et al.. (2021). Reactivation of SARS-CoV-2 infection following recovery from COVID-19. Journal of Infection and Public Health. 14(5). 620–627. 6 indexed citations
16.
Song, Rui, Bing Han, Meihua Song, et al.. (2020). Clinical and epidemiological features of COVID-19 family clusters in Beijing, China. Journal of Infection. 81(2). e26–e30. 68 indexed citations
17.
Qian, Fang, Guiju Gao, Yangzi Song, et al.. (2020). Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study. BMC Infectious Diseases. 20(1). 910–910. 12 indexed citations
18.
Song, Rui, Wei Yang, Wei Zhang, et al.. (2017). A unique case of human Zika virus infection in association with severe liver injury and coagulation disorders. Scientific Reports. 7(1). 11393–11393. 36 indexed citations
19.
Sun, Jie, Juan Hu, Zhihai Chen, et al.. (2017). PCDD/Fs distribution characteristics and health risk assessment in fly ash discharged from MSWIs in China. Ecotoxicology and Environmental Safety. 139. 83–88. 21 indexed citations
20.
Liu, Xing, Xiaojuan Wang, Jihua Nie, et al.. (2015). Synergistic effect of radon and sodium arsenite on DNA damage in HBE cells. Environmental Toxicology and Pharmacology. 41. 127–131. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiwen Wang Breakdown of academic impact, for papers by John Scott Meschke Breakdown of academic impact, for papers by Kwanrawee Sirikanchana Breakdown of academic impact, for papers by Robert J. Fischer Breakdown of academic impact, for papers by Lifang Jiang Breakdown of academic impact, for papers by Wendy Smith Breakdown of academic impact, for papers by Petros Kokkinos Breakdown of academic impact, for papers by Chenglong Xiong Breakdown of academic impact, for papers by Benu Dhawan Breakdown of academic impact, for papers by Yolanda López‐Vidal
Rankless by CCL
2026